West Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . West Pharmaceutical Services
WST Stock  USD 210.70  6.95  3.41%   
West Pharmaceutical financial statements provide useful quarterly and yearly information to potential West Pharmaceutical Services investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on West Pharmaceutical financial statements helps investors assess West Pharmaceutical's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting West Pharmaceutical's valuation are summarized below:
Gross Profit
998.5 M
Profit Margin
0.1703
Market Capitalization
15.2 B
Enterprise Value Revenue
5.0281
Revenue
2.9 B
There are currently one hundred twenty fundamental gauges for West Pharmaceutical that can be evaluated and compared over time across peers. All traders should confirm West Pharmaceutical's prevalent fundamentals against the performance from 2010 to 2025 and make sure the trends continue to evolve in the right direction. Market Cap is likely to drop to about 236.5 M in 2025. Enterprise Value is likely to drop to about 252.4 M in 2025

West Pharmaceutical Total Revenue

3.04 Billion

Check West Pharmaceutical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among West Pharmaceutical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 163.2 M, Total Revenue of 3 B or Gross Profit of 1 B, as well as many indicators such as Price To Sales Ratio of 8.68, Dividend Yield of 0.0023 or PTB Ratio of 9.36. West financial statements analysis is a perfect complement when working with West Pharmaceutical Valuation or Volatility modules.
  
Check out the analysis of West Pharmaceutical Correlation against competitors.

West Pharmaceutical Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets3.8 B3.6 B2.3 B
Slightly volatile
Short and Long Term Debt Total233 M302.3 M291.7 M
Very volatile
Other Current Liabilities203 M193.3 M126.1 M
Slightly volatile
Total Current Liabilities577.9 M550.4 M368 M
Slightly volatile
Total Stockholder Equity2.8 B2.7 B1.6 B
Slightly volatile
Property Plant And Equipment Net1.8 B1.7 B952.1 M
Slightly volatile
Retained Earnings4.2 B4 B1.8 B
Slightly volatile
Cash508.8 M484.6 M397.3 M
Slightly volatile
Non Current Assets Total2.2 B2.1 B1.3 B
Slightly volatile
Non Currrent Assets Other78 M74.3 M34.7 M
Slightly volatile
Cash And Short Term Investments508.8 M484.6 M398.6 M
Slightly volatile
Net Receivables580.1 M552.5 M311.2 M
Slightly volatile
Common Stock Shares Outstanding74.8 M73.7 M73.8 M
Slightly volatile
Liabilities And Stockholders Equity3.8 B3.6 B2.2 B
Slightly volatile
Non Current Liabilities Total311.4 M410.7 M380.2 M
Very volatile
Inventory395.9 M377 M254 M
Slightly volatile
Other Current Assets130.2 M124 M69.5 M
Slightly volatile
Total Liabilities1 B961.1 M637.3 M
Slightly volatile
Total Current Assets1.6 B1.5 B1 B
Slightly volatile
Short Term Debt23.1 M17.9 M39.5 M
Pretty Stable
Intangible Assets10.3 M10.8 M27.7 M
Slightly volatile
Accounts Payable251.3 M239.3 M155.1 M
Slightly volatile
Property Plant And Equipment Gross3.2 B3.1 B1.4 B
Slightly volatile
Common Stock Total Equity13 M21.6 M16.2 M
Slightly volatile
Common Stock13.6 M21.6 M16.3 M
Slightly volatile
Other Liabilities107.9 M130.2 M120.3 M
Pretty Stable
Long Term Debt201.4 M202.6 M237.7 M
Slightly volatile
Good Will103.7 M106.1 M104.7 M
Slightly volatile
Property Plant Equipment1.4 B1.3 B873.7 M
Slightly volatile
Current Deferred Revenue38.2 M49.6 M40.9 M
Very volatile
Net Tangible Assets3.1 B2.9 B1.5 B
Slightly volatile
Long Term Debt Total209.4 M186 M255.6 M
Slightly volatile
Capital Surpluse223.1 M267 M210.2 M
Slightly volatile
Long Term Investments140.1 M202.1 M123.9 M
Slightly volatile
Non Current Liabilities Other98.3 M62.2 M124.1 M
Slightly volatile
Deferred Long Term Asset Charges12 M12.6 M41.2 M
Slightly volatile
Short and Long Term Debt161.8 M154.1 M44.6 M
Slightly volatile
Cash And Equivalents548.1 M1 B448.5 M
Slightly volatile
Net Invested Capital2.5 B2.9 B2 B
Slightly volatile
Net Working Capital1 B987.7 M733.6 M
Slightly volatile
Capital Stock15 M16.9 M18.4 M
Slightly volatile
Capital Lease Obligations96.4 M99.7 M79.4 M
Slightly volatile

West Pharmaceutical Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization163.2 M155.4 M102 M
Slightly volatile
Total Revenue3 B2.9 B1.9 B
Slightly volatile
Gross Profit1 B998.5 M659.3 M
Slightly volatile
Other Operating Expenses2.4 B2.3 B1.5 B
Slightly volatile
Operating Income598.4 M569.9 M340.1 M
Slightly volatile
EBIT617.9 M588.5 M348.5 M
Slightly volatile
EBITDA781.1 M743.9 M450.5 M
Slightly volatile
Cost Of Revenue2 B1.9 B1.2 B
Slightly volatile
Total Operating Expenses450 M428.6 M313.1 M
Slightly volatile
Income Before Tax614.8 M585.5 M333.2 M
Slightly volatile
Net Income517.3 M492.7 M277.9 M
Slightly volatile
Income Tax Expense112.9 M107.5 M65.8 M
Slightly volatile
Selling General Administrative200.4 M338.5 M255.9 M
Slightly volatile
Research Development35.4 M69.1 M42.3 M
Slightly volatile
Net Income Applicable To Common Shares707.5 M673.8 M296.6 M
Slightly volatile
Net Income From Continuing Ops283.5 M492.7 M259.4 M
Slightly volatile
Tax Provision86.5 M107.5 M62.8 M
Slightly volatile
Interest Income20.6 M19.6 M10.5 M
Pretty Stable
Reconciled Depreciation130.5 M155.4 M109.8 M
Slightly volatile

West Pharmaceutical Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation12.5 M18.7 M20 M
Slightly volatile
Free Cash Flow290.2 M276.4 M185.6 M
Slightly volatile
Begin Period Cash Flow896.6 M853.9 M397.9 M
Slightly volatile
Depreciation163.2 M155.4 M102.6 M
Slightly volatile
Capital Expenditures395.9 M377 M190.1 M
Slightly volatile
Total Cash From Operating Activities686.1 M653.4 M375.7 M
Slightly volatile
Net Income517.3 M492.7 M278.3 M
Slightly volatile
End Period Cash Flow508.8 M484.6 M396.9 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio8.688.26495.2978
Slightly volatile
Dividend Yield0.00230.00250.0066
Slightly volatile
PTB Ratio9.368.91476.3619
Slightly volatile
Days Sales Outstanding43.0669.702255.1703
Slightly volatile
Book Value Per Share38.5836.743822.7024
Slightly volatile
Free Cash Flow Yield0.0110.01160.0188
Slightly volatile
Operating Cash Flow Per Share9.48.95075.141
Slightly volatile
Stock Based Compensation To Revenue0.00870.00650.0113
Pretty Stable
Capex To Depreciation1.262.4261.6894
Slightly volatile
PB Ratio9.368.91476.3619
Slightly volatile
EV To Sales8.618.20185.2822
Slightly volatile
Free Cash Flow Per Share3.983.78632.5273
Slightly volatile
ROIC0.160.14960.1208
Slightly volatile
Inventory Turnover6.385.02575.1017
Slightly volatile
Net Income Per Share7.096.74933.789
Slightly volatile
Days Of Inventory On Hand52.0472.626372.1425
Slightly volatile
Payables Turnover11.87.91778.6647
Slightly volatile
Sales General And Administrative To Revenue0.180.15310.1628
Pretty Stable
Research And Ddevelopement To Revenue0.0180.02390.0227
Slightly volatile
Capex To Revenue0.110.13030.0962
Pretty Stable
Cash Per Share6.976.63845.4405
Slightly volatile
POCF Ratio38.4336.596126.9887
Slightly volatile
Interest Coverage19919058.708
Slightly volatile
Payout Ratio0.110.120.1998
Slightly volatile
Capex To Operating Cash Flow0.770.5770.5733
Slightly volatile
PFCF Ratio90.8486.511961.8707
Slightly volatile
Days Payables Outstanding28.7546.099443.1648
Slightly volatile
Income Quality1.261.32621.5823
Slightly volatile
ROE0.0960.18370.1515
Slightly volatile
EV To Operating Cash Flow38.1336.317127.0867
Slightly volatile
PE Ratio50.9648.532338.6543
Slightly volatile
Return On Tangible Assets0.150.13970.1129
Slightly volatile
EV To Free Cash Flow90.1485.852362.8117
Slightly volatile
Earnings Yield0.01960.02060.0306
Slightly volatile
Intangibles To Total Assets0.03050.03210.0645
Slightly volatile
Current Ratio1.842.79452.7181
Pretty Stable
Tangible Book Value Per Share36.935.142520.9126
Slightly volatile
Receivables Turnover7.625.23666.7347
Slightly volatile
Graham Number78.4374.698842.302
Slightly volatile
Shareholders Equity Per Share38.5836.743821.4036
Slightly volatile
Debt To Equity0.110.11270.2424
Slightly volatile
Capex Per Share5.425.16442.6137
Slightly volatile
Revenue Per Share41.6139.632925.9788
Slightly volatile
Interest Debt Per Share2.544.18224.0379
Very volatile
Debt To Assets0.07880.0830.1457
Slightly volatile
Enterprise Value Over EBITDA33.4931.898922.1465
Slightly volatile
Short Term Coverage Ratios4.955.2225.8912
Pretty Stable
Price Earnings Ratio50.9648.532338.6543
Slightly volatile
Operating Cycle95.1142127
Slightly volatile
Price Book Value Ratio9.368.91476.3619
Slightly volatile
Days Of Payables Outstanding28.7546.099443.1648
Slightly volatile
Dividend Payout Ratio0.110.120.1998
Slightly volatile
Price To Operating Cash Flows Ratio38.4336.596126.9887
Slightly volatile
Price To Free Cash Flows Ratio90.8486.511961.8707
Slightly volatile
Pretax Profit Margin0.210.20240.1566
Slightly volatile
Ebt Per Ebit0.981.02740.9586
Slightly volatile
Operating Profit Margin0.210.1970.1613
Slightly volatile
Effective Tax Rate0.290.18360.2443
Slightly volatile
Company Equity Multiplier2.11.35831.6066
Slightly volatile
Long Term Debt To Capitalization0.06670.07020.1595
Slightly volatile
Total Debt To Capitalization0.09620.10130.185
Slightly volatile
Return On Capital Employed0.10.18430.1548
Slightly volatile
Debt Equity Ratio0.110.11270.2424
Slightly volatile
Ebit Per Revenue0.210.1970.1613
Slightly volatile
Quick Ratio1.292.10961.9784
Slightly volatile
Dividend Paid And Capex Coverage Ratio1.031.49831.5285
Slightly volatile
Net Income Per E B T0.590.84150.7812
Slightly volatile
Cash Ratio0.470.88050.9616
Slightly volatile
Cash Conversion Cycle95.1896.229187.7488
Slightly volatile
Operating Cash Flow Sales Ratio0.120.22580.1751
Slightly volatile
Days Of Inventory Outstanding52.0472.626372.1425
Slightly volatile
Days Of Sales Outstanding43.0669.702255.1703
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.240.4230.4273
Slightly volatile
Cash Flow Coverage Ratios2.272.16141.2978
Slightly volatile
Price To Book Ratio9.368.91476.3619
Slightly volatile
Fixed Asset Turnover1.581.71591.9887
Very volatile
Capital Expenditure Coverage Ratio1.271.73321.8969
Slightly volatile
Price Cash Flow Ratio38.4336.596126.9887
Slightly volatile
Enterprise Value Multiple33.4931.898922.1465
Slightly volatile
Debt Ratio0.07880.0830.1457
Slightly volatile
Cash Flow To Debt Ratio2.272.16141.2978
Slightly volatile
Price Sales Ratio8.688.26495.2978
Slightly volatile
Return On Assets0.140.13520.1064
Slightly volatile
Asset Turnover0.980.79410.8616
Pretty Stable
Net Profit Margin0.180.17030.1273
Slightly volatile
Gross Profit Margin0.260.34510.3331
Slightly volatile
Price Fair Value9.368.91476.3619
Slightly volatile
Return On Equity0.0960.18370.1515
Slightly volatile

West Pharmaceutical Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap236.5 M442.1 M454.3 M
Very volatile
Enterprise Value252.4 M374.8 M391.7 M
Very volatile

West Fundamental Market Drivers

Forward Price Earnings33.4448
Cash And Short Term Investments484.6 M

West Upcoming Events

15th of February 2024
Upcoming Quarterly Report
View
25th of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
15th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About West Pharmaceutical Financial Statements

West Pharmaceutical shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although West Pharmaceutical investors may analyze each financial statement separately, they are all interrelated. The changes in West Pharmaceutical's assets and liabilities, for example, are also reflected in the revenues and expenses on on West Pharmaceutical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue49.6 M38.2 M
Total Revenue2.9 B3 B
Cost Of Revenue1.9 B2 B
Stock Based Compensation To Revenue 0.01  0.01 
Sales General And Administrative To Revenue 0.15  0.18 
Research And Ddevelopement To Revenue 0.02  0.02 
Capex To Revenue 0.13  0.11 
Revenue Per Share 39.63  41.61 
Ebit Per Revenue 0.20  0.21 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for West Stock Analysis

When running West Pharmaceutical's price analysis, check to measure West Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy West Pharmaceutical is operating at the current time. Most of West Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of West Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move West Pharmaceutical's price. Additionally, you may evaluate how the addition of West Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY